# Michael Fu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-fu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,390 |
| Field | Heart Failure Treatment and Management |
| h-index | 49 |
| i10-index | 155 |
| Last Known Institution | Rutgers, The State University of New Jersey |
| OpenAlex ID | https://openalex.org/A5027994405 |
| ORCID iD | https://orcid.org/0000-0001-8860-1051 |
| Works | 279 |

## Researcher papers

- [Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases](https://scholariq.org/papers/current-state-of-knowledge-on-aetiology-diagnosis-management-and-therapy-of/)
- [How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)](https://scholariq.org/papers/how-to-diagnose-heart-failure-with-preserved-ejection-fraction-the-hfa-peff/)
- [SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe](https://scholariq.org/papers/score2-risk-prediction-algorithms-new-models-to-estimate-10-year-risk-of/)
- [Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity](https://scholariq.org/papers/semaglutide-in-patients-with-heart-failure-with-preserved-ejection-fraction-and/)
- [The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial](https://scholariq.org/papers/the-sglt2-inhibitor-empagliflozin-in-patients-hospitalized-for-acute-heart/)
- [Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure](https://scholariq.org/papers/angiotensin-receptor-neprilysin-inhibition-compared-with-enalapril-on-the-risk/)
- [Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes](https://scholariq.org/papers/semaglutide-in-patients-with-obesity-related-heart-failure-and-type-2-diabetes/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Viral Infections and Immunology Research](https://scholariq.org/topics/viral-infections-and-immunology-research-2/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Receptor Mechanisms and Signaling](https://scholariq.org/topics/receptor-mechanisms-and-signaling/)

## Researcher university

- [Rutgers, The State University of New Jersey](https://scholariq.org/institutions/rutgers-the-state-university-of-new-jersey/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.